Free Trial

FY2025 EPS Estimates for Core Scientific Cut by Roth Capital

Core Scientific logo with Finance background

Core Scientific, Inc. (NASDAQ:CORZ - Free Report) - Equities researchers at Roth Capital lowered their FY2025 earnings estimates for shares of Core Scientific in a report issued on Tuesday, January 7th. Roth Capital analyst D. Aftahi now forecasts that the company will post earnings per share of ($0.30) for the year, down from their previous forecast of ($0.29). Roth Capital has a "Strong-Buy" rating on the stock. The consensus estimate for Core Scientific's current full-year earnings is $0.50 per share. Roth Capital also issued estimates for Core Scientific's Q4 2025 earnings at ($0.01) EPS and FY2026 earnings at $0.33 EPS.

Other equities analysts have also issued reports about the company. Jefferies Financial Group initiated coverage on Core Scientific in a report on Monday, October 28th. They issued a "buy" rating and a $19.00 price objective for the company. Macquarie raised their price target on Core Scientific from $16.00 to $19.00 and gave the company an "outperform" rating in a report on Thursday, November 14th. B. Riley lifted their price objective on shares of Core Scientific from $16.00 to $17.00 and gave the company a "buy" rating in a research note on Thursday, November 7th. Compass Point increased their target price on shares of Core Scientific from $18.00 to $20.00 and gave the company a "buy" rating in a research report on Wednesday, October 23rd. Finally, Canaccord Genuity Group restated a "buy" rating and set a $17.00 price target on shares of Core Scientific in a research report on Thursday, November 7th. Thirteen equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Buy" and an average target price of $18.46.

Get Our Latest Stock Analysis on Core Scientific

Core Scientific Stock Performance

Shares of NASDAQ:CORZ traded down $0.07 during trading hours on Thursday, hitting $14.05. The stock had a trading volume of 7,942,430 shares, compared to its average volume of 9,765,390. The stock's fifty day simple moving average is $15.62 and its 200 day simple moving average is $12.56. The firm has a market capitalization of $3.92 billion and a price-to-earnings ratio of -2.60. Core Scientific has a 1-year low of $2.61 and a 1-year high of $18.63.

Hedge Funds Weigh In On Core Scientific

Several institutional investors and hedge funds have recently added to or reduced their stakes in CORZ. JPMorgan Chase & Co. boosted its position in shares of Core Scientific by 48.0% in the third quarter. JPMorgan Chase & Co. now owns 437,812 shares of the company's stock worth $5,192,000 after buying an additional 142,068 shares during the period. Sanctuary Advisors LLC boosted its position in Core Scientific by 130.1% during the 3rd quarter. Sanctuary Advisors LLC now owns 34,527 shares of the company's stock worth $409,000 after acquiring an additional 19,522 shares during the period. Neo Ivy Capital Management purchased a new position in Core Scientific during the 3rd quarter valued at about $194,000. Geode Capital Management LLC increased its holdings in shares of Core Scientific by 26.7% in the 3rd quarter. Geode Capital Management LLC now owns 5,276,573 shares of the company's stock valued at $62,594,000 after purchasing an additional 1,113,285 shares during the period. Finally, Sender Co & Partners Inc. purchased a new stake in shares of Core Scientific in the third quarter worth approximately $2,426,000.

Insiders Place Their Bets

In other Core Scientific news, CEO Adam Taylor Sullivan sold 88,380 shares of the business's stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $14.24, for a total transaction of $1,258,531.20. Following the sale, the chief executive officer now owns 4,128,505 shares in the company, valued at approximately $58,789,911.20. The trade was a 2.10 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Todd M. Duchene sold 25,000 shares of the firm's stock in a transaction dated Wednesday, November 20th. The stock was sold at an average price of $17.10, for a total transaction of $427,500.00. Following the completion of the transaction, the insider now owns 1,661,474 shares of the company's stock, valued at approximately $28,411,205.40. The trade was a 1.48 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 348,241 shares of company stock worth $5,436,802. 32.00% of the stock is owned by insiders.

Core Scientific Company Profile

(Get Free Report)

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.

Featured Articles

Earnings History and Estimates for Core Scientific (NASDAQ:CORZ)

Should You Invest $1,000 in Core Scientific Right Now?

Before you consider Core Scientific, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Scientific wasn't on the list.

While Core Scientific currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why the Latest Jobs Data Has Wall Street Nervous
7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025
3 Stocks Insiders Are Selling, But Analysts Still Love

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines